West Virginia House Bill HB4771

West Virginia 2026 Regular Session

• Introduced: 1/23/26
• Refer: 1/23/26

Caption

Relating to access of records in controlled substance monitoring

Summary

HB4771 amends West Virginia’s controlled substances monitoring law to expand who may access the state’s Controlled Substances Monitoring Program Database, which is maintained by the Board of Pharmacy. The bill specifically adds licensed healthcare professionals certified as medical examiners by the Federal Motor Carrier Safety Administration to the list of authorized users. It also retains and restates the existing framework governing confidentiality, limited access, reporting, and use of the database for patient care, investigations, and regulatory oversight. Beyond adding that new access category, the bill continues the database’s broader structure for identifying abnormal or unusual prescribing and dispensing patterns. It preserves the Board of Pharmacy’s authority to review data, generate confidential reports, and share information with licensing boards, law enforcement, and other specified entities under defined conditions. The bill also maintains provisions for advisory and review committees, rulemaking, annual reporting, and immunity protections for good-faith reporting and reliance on database information.

Impact

The bill would amend §60A-9-5 of the West Virginia Code, the section governing confidentiality and access to the Controlled Substances Monitoring Program Database. Its principal legal effect is to expand statutory access to include FMCSA-certified medical examiners, allowing them to inspect relevant controlled-substance prescribing information for purposes tied to federal commercial driver medical certification. The bill does not broadly open the database; access remains limited, confidential, and subject to existing restrictions, reporting rules, and privacy protections.

Sentiment

The available context suggests the bill is generally noncontroversial and technical in nature. The stated purpose is narrowly focused on adding qualified federal motor carrier medical examiners to the list of authorized database users, which indicates a targeted administrative or public-safety adjustment rather than a major policy shift. No committee debate or recorded votes were provided, so there is no evidence of organized opposition in the available materials.

Contention

Because no committee transcripts or vote history are available, there are no documented points of contention in the record provided. Potential areas of concern, based on the bill text, would likely center on privacy, confidentiality, and the scope of access to prescription-monitoring data, but the bill preserves the existing limits and safeguards. Any discussion would likely involve whether expanding access to medical examiners is necessary and whether that access should be narrowly tailored to commercial driver fitness evaluations.